Back to Search Start Over

Pre-procedural predictive factors of symptomatic intracranial hemorrhage after thrombectomy in stroke.

Authors :
Venditti, Laura
Chassin, Olivier
Ancelet, Claire
Legris, Nicolas
Sarov, Mariana
Lapergue, Bertrand
Mihalea, Cristian
Ozanne, Augustin
Gallas, Sophie
Cortese, Jonathan
Chalumeau, Vanessa
Ikka, Leon
Caroff, Jildaz
Labreuche, Julien
Spelle, Laurent
Denier, Christian
Source :
Journal of Neurology; May2021, Vol. 268 Issue 5, p1867-1875, 9p
Publication Year :
2021

Abstract

Objective: Symptomatic intracerebral hemorrhage (sICH) is a common complication of acute ischemic stroke (AIS) associated with limited treatments and poor outcomes. We aimed to identify predictive factors of sICH in patients with AIS following mechanical thrombectomy (MT) in a real-world setting. Methods: Patients with large vessel occlusion of the anterior circulation treated with MT were consecutively included in a prospective monocentric cohort. Clinical, biological, and radiological parameters were collected to identify pre-procedural predictors for sICH. Results: 637 patients were included in our study. Magnetic resonance imaging was performed on most patients (86.7%). sICH occurred in 55 patients (8.6%). 428 patients (67.2%) were treated with intravenous thrombolysis. After multivariate analysis, prior use of antiplatelet therapies (odd ratio (OR) 1.84, 95% confidence interval (CI) 1.01–3.32), high C-reactive protein (OR per standard deviation (SD) increase 1.28, 95% 1.01–1.63), elevated mean arterial blood pressure (OR per 10 mmHg increase 1.22, 95% CI 1.03–1.44), hyperglycemia (OR per one SD-log increase 1.38, 95% CI 1.02–1.87), and low ASPECTS (OR per 1-point decrease 1.42, 95% CI 1.12–1.80) were found to be independent predictive factors of sICH. The pre-procedural predictors did not change when the absence of successful recanalization was considered as a covariate. Patients with strokes of unknown onset time were not especially vulnerable for sICH. Conclusion: sICH after MT was associated with several pre-procedural risk factors: prior use of antiplatelet therapies, high C-reactive protein and hyperglycemia at baseline, elevated mean arterial blood pressure, and low ASPECTS. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
03405354
Volume :
268
Issue :
5
Database :
Complementary Index
Journal :
Journal of Neurology
Publication Type :
Academic Journal
Accession number :
149989253
Full Text :
https://doi.org/10.1007/s00415-020-10364-x